When did Twist Bioscience Corporation report Q1 2025 earnings?

Twist Bioscience Corporation (TWST) reported Q1 2025 earnings on February 3, 2025 before market open.

What were Twist Bioscience Corporation's Q1 2025 revenue and EPS?

Twist Bioscience Corporation reported revenue of $88.7M and eps of $-0.53 for Q1 2025.

Did Twist Bioscience Corporation beat estimates in Q1 2025?

Revenue beat the consensus estimate of $86.9M by $1.8M. EPS beat the consensus estimate of $-0.62 by $0.09.

Where can I find Twist Bioscience Corporation's Q1 2025 SEC filings?

You can read the 10-Q periodic report (0001628280-25-003461) directly on SEC EDGAR. The filing index links above go to sec.gov.

Twist Bioscience Corporation TWST Q1 2025 earnings

Reported February 3, 2025 · Before market open

Revenue$88.7MBeat by $1.8M

EPS-$0.53Beat by $0.09

Revenue estimate$86.9M

EPS estimate-$0.62

Next report

Aug 3, 2026 (In 5 days)

Revenue estimate$114.5M

EPS estimate-$0.50

Financials

Q1 2025

Income statement

See full

Revenue$88.7M+24.1%

Gross profit$42.8M+47.9%

Operating income-$34.6M+26.3%

Net income-$31.6M+26.5%

EPS (diluted)-$0.53+29.3%

Balance sheet

See full

Cash & equivalents$224.1M-16.7%

Total debt$97.6M+6.2%

Total equity$455.9M-22.7%

Total assets$608.6M-17.0%

Cash flow

See full

Operating cash flow-$21.4M+6.7%

CapEx$2.3M+50.6%

Free cash flow-$23.7M+3.2%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.76B+30.1%

Enterprise value$2.63B+35.5%

P/S8.4×+0.3×

Profitability

See full

Gross margin44.6%+8.8pp

Operating margin-63.1%-12.4pp

Net margin-59.8%-11.5pp

FCF margin-20.7%-7.6pp

Returns & leverage

See full

Return on equity-37.7%+10.9pp

Debt / equity0.2×+0.1×

Current ratio5×-1.0×

Segments

By geography

See full

Americas$53.7M+22.2%

EMEA$28.3M+33.4%

APAC$6.7M+6.0%

By product

See full

NGS applications$48.6M+23.4%

DNA synthesis and protein solutions$40.1M+667%

By segment

See full

Reportable Segment$88.7M+13.4%

Versus estimates

Revenue

Q2 2026$110.7MBeat by $3.1M Q1 2026$103.7MBeat by $1.8M Q4 2025$99.0MBeat by $1.6M Q3 2025$96.1MMiss by $1.3M Q2 2025$92.8MMiss by $2.6M

Q1 2025$88.7MBeat by $1.8M

Diluted EPS

Q2 2026-$0.62Miss by $0.13 Q1 2026-$0.50Miss by $0.02 Q4 2025-$0.45Beat by $0.05 Q3 2025-$0.47Beat by $0.07 Q2 2025-$0.66Miss by $0.10

Q1 2025-$0.53Beat by $0.09

Ask the moment Twist Bioscience Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Twist Bioscience Corporation report Q1 2025 earnings?: Twist Bioscience Corporation (TWST) reported Q1 2025 earnings on February 3, 2025 before market open.
What were Twist Bioscience Corporation's Q1 2025 revenue and EPS?: Twist Bioscience Corporation reported revenue of $88.7M and eps of $-0.53 for Q1 2025.
Did Twist Bioscience Corporation beat estimates in Q1 2025?: Revenue beat the consensus estimate of $86.9M by $1.8M. EPS beat the consensus estimate of $-0.62 by $0.09.
Where can I find Twist Bioscience Corporation's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001628280-25-003461) directly on SEC EDGAR. The filing index links above go to sec.gov.